Candriam SCA’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-181,901
| Closed | -$5.32M | – | 713 |
|
|
2024
Q1 | $5.32M | Sell |
181,901
-10,000
| -5% | -$292K | 0.03% | 331 |
|
|
2023
Q4 | $6.48M | Buy |
191,901
+40,000
| +26% | +$1.35M | 0.04% | 307 |
|
|
2023
Q3 | $4.66M | Sell |
151,901
-40,000
| -21% | -$1.23M | 0.03% | 316 |
|
|
2023
Q2 | $7.69M | Buy |
191,901
+12,000
| +7% | +$481K | 0.06% | 280 |
|
|
2023
Q1 | $6.76M | Sell |
179,901
-45,000
| -20% | -$1.69M | 0.05% | 310 |
|
|
2022
Q4 | $11.1M | Buy |
224,901
+45,000
| +25% | +$2.21M | 0.07% | 252 |
|
|
2022
Q3 | $9.57M | Buy |
179,901
+50,000
| +38% | +$2.66M | 0.07% | 282 |
|
|
2022
Q2 | $7.57M | Sell |
129,901
-44,180
| -25% | -$2.58M | 0.06% | 267 |
|
|
2022
Q1 | $13.3M | Sell |
174,081
-56,000
| -24% | -$4.27M | 0.09% | 214 |
|
|
2021
Q4 | $13.8M | Buy |
230,081
+25,121
| +12% | +$1.51M | 0.09% | 221 |
|
|
2021
Q3 | $11.5M | Buy |
+204,960
| New | +$11.5M | 0.08% | 251 |
|
|
2018
Q3 | – | Sell |
-44,440
| Closed | -$1.42M | – | 835 |
|
|
2018
Q2 | $1.42M | Hold |
44,440
| – | – | 0.02% | 547 |
|
|
2018
Q1 | $1.38M | Sell |
44,440
-2,560
| -5% | -$79.7K | 0.02% | 538 |
|
|
2017
Q4 | $2.15M | Sell |
47,000
-6,000
| -11% | -$274K | 0.04% | 437 |
|
|
2017
Q3 | $1.99M | Hold |
53,000
| – | – | 0.03% | 458 |
|
|
2017
Q2 | $2.53M | Sell |
53,000
-7,000
| -12% | -$334K | 0.05% | 418 |
|
|
2017
Q1 | $2.74M | Buy |
+60,000
| New | +$2.74M | 0.05% | 379 |
|
|
2015
Q1 | – | Sell |
-36,000
| Closed | -$3.19M | – | 654 |
|
|
2014
Q4 | $3.19M | Buy |
+36,000
| New | +$3.19M | 0.07% | 300 |
|